Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases (BIOMIS-Nefro)
Costituzione Della Biobanca Del Microbiota Intestinale e Salivare Umano: Dalla Disbiosi Alla Simbiosi
Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Listed as NCT04689074, this observational or N/A phase trial focuses on Advanced-Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) and remains completed. Sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
-
Sep 2022 — Nov 2023 [monthly]
Completed
Status: Recruiting → Completed
-
Apr 2022 — Sep 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Feb 2022 — Apr 2022 [monthly]
Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — May 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
- Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies
- Istituti Tumori Giovanni Paolo II
- University Of Perugia
- University of Bari Aldo Moro
- University of Salento
For direct contact, visit the study record on ClinicalTrials.gov .